@article{Amador_Vargas Rodríguez_Hernández_Sanabria Aguilar_Bolívar Córdoba_Ruiz Muñoz_Romero Cely_Aborashed Amador_2022, title={Hepatorenal syndrome: Literature review}, volume={9}, url={https://revistanefrologia.org/index.php/rcn/article/view/539}, DOI={10.22265/acnef.9.1.539}, abstractNote={<p><strong>Background</strong>: Hepatorenal syndrome is a renal dysfunction that occurs in patients with chronic liver disease such as liver cirrhosis or acute liver disease, characterized by the activation of regulatory mechanisms that lead to a decrease in the glomerular filtration rate. Clinically, hepatorenal syndrome is divided into two types, type 1 and type 2. Type 1 is characterized by a rapid and progressive loss of kidney function while type 2 is characterized by slow progression and a better prognosis.</p> <p><strong>Purpose</strong>: To analyze the natural history of the disease presented by patients who develop hepatorenal syndrome.</p> <p><strong>Methodology</strong>: A review of the scientific literature of published manuscripts on hepatorenal syndrome was carried out to evaluate the natural history of this pathology.</p> <p><strong>Results</strong>:There are no specific clinical findings, however, its clinical manifestations reflect the underlying advanced liver disease, kidney failure, and circulatory abnormalities present.</p> <p><strong>Conclusions: </strong>The most appropriate therapeutic option is liver transplantation, but not all patients can receive it, while accessing said management an option is drug treatment with vasoconstrictors and albumin</p>}, number={1}, journal={Revista Colombiana de Nefrología}, author={Amador, Annia Cristina and Vargas Rodríguez, Ledmar Jovanny and Hernández, Geovanny and Sanabria Aguilar, Diana Paola and Bolívar Córdoba, Paola Andrea and Ruiz Muñoz, Jeinny Lucero and Romero Cely, Mónica Dayana and Aborashed Amador, Nahala Fahed}, year={2022}, month={Feb.}, pages={e539} }